Genetic variability of subgroup A and B respiratory syncytial virus strains circulating in southwestern China from 2009 to 2011

Qin, Xian; Zhang, Cui; Zhao, Yao; Zhao, Xiaodong
July 2013
Archives of Virology;Jul2013, Vol. 158 Issue 7, p1487
Academic Journal
Human respiratory syncytial virus (RSV) is recognized as a leading pathogen responsible for severe respiratory infections in the pediatric population, particularly in infants and young children. A previous study by the same study group revealed that the RSV BA strain was prevalent in southwestern China in epidemic seasons from 2008 to 2009. The aim of this study was to investigate the epidemiology of RSV in the following two years, the genetic variability of the G gene, and mutations at the 276th amino acid in the fusion (F) protein of RSV strains. Nine BA substrains were found in 16 subgroup B viruses by phylogenetic analysis. The G gene of genotype BA was predicted to encode proteins with five different lengths. The findings indicate that subgroup A and B RSVs alternately circulate in southwestern China and that genotype BA strains appear to be the long-term circulating ones. These epidemiological data may help in future vaccine design and further investigation of G protein function.


Related Articles

  • Epidemiología y datos clínicos de la infección por el virus respiratorio sincitial en niños mayores de 2 años hospitalizados. Estudio multicéntrico nacional (FIVE). Calvo, C.; Moreno-Pérez, D. // Acta Pediátrica Española;ene2015, Vol. 73 Issue 1, p5 

    Introduction and objectives: Respiratory syncytial virus (RSV) infections are well characterized in infants. However, few studies are focused in RSV disease in children over 2 of age. Our goal is to analyze the characteristics of children older than 2 hospitalized due to RSV infection in the...

  • Sequencing and Analysis of Globally Obtained Human Respiratory Syncytial Virus A and B Genomes. Bose, Michael E.; He, Jie; Shrivastava, Susmita; Nelson, Martha I.; Bera, Jayati; Halpin, Rebecca A.; Town, Christopher D.; Lorenzi, Hernan A.; Noyola, Daniel E.; Falcone, Valeria; Gerna, Giuseppe; De Beenhouwer, Hans; Videla, Cristina; Kok, Tuckweng; Venter, Marietjie; Williams, John V.; Henrickson, Kelly J. // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Background: Human respiratory syncytial virus (RSV) is the leading cause of respiratory tract infections in children globally, with nearly all children experiencing at least one infection by the age of two. Partial sequencing of the attachment glycoprotein gene is conducted routinely for...

  • Gene Sequence Variability of the Three Surface Proteins of Human Respiratory Syncytial Virus (HRSV) in Texas. Tapia, Lorena I.; Shaw, Chad A.; Aideyan, Letisha O.; Jewell, Alan M.; Dawson, Brian C.; Haq, Taha R.; Piedra, Pedro A. // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    Human respiratory syncytial virus (HRSV) has three surface glycoproteins: small hydrophobic (SH), attachment (G) and fusion (F), encoded by three consecutive genes (SH-G-F). A 270-nt fragment of the G gene is used to genotype HRSV isolates. This study genotyped and investigated the variability...

  • Progress and Challenges in RSV Prophylaxis and Vaccine Development. Haynes, Lia M. // Journal of Infectious Diseases;Dec2013 Supplement 3, Vol. 208, pS177 

    The article focuses on the respiratory syncytial virus (RSV) that cause respiratory tract disease in children under five. It states that RSV infected children die in most of the cases. Currently licensed vaccine is not available to prevent this virus, but scientists are engaged in inventing one....

  • Prevention, management of RSV critical in pediatric cancer. Southall, Jennifer // Hem/Onc Today;2/25/2008, Vol. 9 Issue 3, p15 

    The article discusses research being done on the risk factors for severe respiratory syncytial virus (RSV) disease in children with cancer. It references a study by C. M. Saleeby et al, published in the 2008 issue of "Pediatrics." The researchers found that neutropenia is not associated with...

  • Human respiratory syncytial virus in children hospitalized for acute lower respiratory infection. Salomão Junior, João B.; Gardinassi, Luiz G. A.; Simas, Paulo V. M.; Bittar, Cintia O.; Souza, Fátima P.; Rahal, Paula; Zanetta, Dirce M. T. // Jornal de Pediatria;May/Jun2011, Vol. 87 Issue 3, p219 

    Objective: To evaluate the prevalence and seasonality of human respiratory syncytial virus (HRSV) in children aged 0 to 6 years, hospitalized with acute lower respiratory infection (ALRI) in São José do Rio Preto, SP, Brazil, and the association between age, diagnosis, and HRSV. Methods:...

  • Hospitalization due to respiratory syncytial virus infection in patients under 2 years of age with hemodynamically significant congenital heart disease. Andres, Silvia; Bauer, Gabriela; Rodríguez, Susana; Novali, Luis; Micheli, Diego; Fariña, Diana // Jornal de Pediatria;May/Jun2012, Vol. 88 Issue 3, p246 

    Objective: To describe hospitalization rates, burden of disease, and associated risk factors of acute respiratory infections (ARI), particularly those caused by respiratory syncytial virus (RSV) and non-RSV-ARI, in a cohort of patients under 2 years of age with congenital heart disease (CHD)....

  • 'Tricorder' device will detect infection and immune response to it. Knight, Helen // Engineer (Online Edition);10/14/2015, p5 

    The article provides information on the point of care sensor being developed by a European Union (EU)-funded consortium that could detect the presence of respiratory syncytial infection (RSV) in children. It states that the RSV virus can occasionally lead to severe conditions like bronchiolitis...

  • Attenuation of Live Respiratory Syncytial Virus Vaccines Is Associated With Reductions in Levels of Nasal Cytokines. Karron, Ruth A.; Thumar, Bhagvanji; Schappell, Elizabeth; Buchholz, Ursula J.; Collins, Peter L. // Journal of Infectious Diseases;Jun2013, Vol. 207 Issue 11, p1773 

    Background. Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract illness (LRTI) in children. Several promising live-attenuated RSV vaccines are in development. Defining additional markers of attenuation could enhance clinical trials.Methods. We used clinical data,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics